Search
for
Sort by
Research 31–60 of 1000+
- Strontium: A Potent and Selective Inhibitor of Sensory Irritation and Topical Anti-inflammatory
- Review of the Efficacy of Topical 5-Alpha Reductase Inhibitors for the Treatment of Androgenetic Alopecia
- Discovery of 7-Methoxy-6-[4-(4-methyl-1,3-thiazol-2-yl)-1<i>H</i>-imidazol-5-yl]-1,3-benzothiazole (TASP0382088): A Potent and Selective Transforming Growth Factor-β Type I Receptor Inhibitor as a Topical Drug for Alopecia
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- JAK inhibitors in dermatology: The promise of a new drug class
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Topical tofacitinib solution for the treatment of alopecia areata affecting eyelashes
- Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence
- Janus Kinase Inhibitors for Alopecia Areata
- A review of Janus kinase inhibitor use in scarring alopecia
- [JAK INHIBITORS FOR THE TREATMENT OF ALOPECIA AREATA].
- Janus kinase inhibitors for alopecia areata: A narrative review
- Janus Kinase inhibitors in dermatology: a review
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Jak inhibitors in the treatment of alopecia areata - a literature review
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- JAK inhibitors for alopecia areata: a systematic review and meta‐analysis
- Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened
- JAK-inhibitors in dermatology: current evidence and future applications
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Emerging drugs for alopecia areata: JAK inhibitors
- The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Eosinophilic folliculitis of the scalp associated with PD‐1/PDL1 inhibitors
- TNF inhibitor induced alopecia: an unusual form of psoriasiform alopecia that breaks the Renbök mold
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report